Exabis Library
Welcome to the e-CCO Library!
P012 α4β7 Receptor occupancy by vedolizumab at trough time-point occurs at the membranal level and is not associated with endoscopic healing in inflammatory bowel disease patients
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P0120: Study of the Implication of the Epithelium in the Development and Progression of Fibrosis in Ulcerative Colitis
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0121: Molecular features of extracellular matrix activity persist in patients who achieve mucosal healing with ustekinumab induction
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0122: The Potential Role of Circulating Cytokines and Chemokines To Predict Intestinal Failure in Patients Affected by Short Bowel Syndrome
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0123: The immune system of patients with immune-mediated diseases perceives dysbiotic intestinal microbial speciesx7x7x7 and IgG reactivity uncovers shared and non-shared responses across diseases
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0124: Therapeutic Potential of Adipose-Derived Extracellular Vesicles for Inflammation Modulation and Mucosal Healing in Crohn’s Disease
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0125: Crohn’s-associated invariant T Cells are associated with disease severity and location and are not affected by medication intake
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0126: Single-cell analysis reveals enrichment of mucosal Th17-polarized T cells in Acute Severe Ulcerative Colitis
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0127: Fistula-derived fibroblasts express genes associated with a dysfunctional wound healing process
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0128: IL-27 signallingx7x7x7 but not IL-1Bx7x7x7 is functionally relevant in the pathophysiology of immune checkpoint inhibitor induced colitis
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0129: Distinct involvement of plasma cells and monocytes/macrophages in ileal and colonic ulcer formation in patients with Crohn's disease
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P012: Identification of ectopic olfactory receptor gene in ulcerative colitis patients and functional analysis of OR51E2 using ex vivo culture of colonic organoid in both human and mice
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P012: IL22 expression in intestinal immune cells is not augmented by AHR activation in health or Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P012: Low frequencies of circulating inhibitory TIGIT+CD38+ effector T cells identify an immunologically distinct subgroup of pediatric patients with severe Crohn's disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P012: MAIT cell activation reflects mucosal inflammation in ulcerative colitis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P012: Ral activation exacerbates colonic inflammation through the impairment of intestinal barrier function in experimental murine colitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P012: The administration of mm-miR-378a-3p exacerbates chronic inflammation and fibrosis in a murine intestinal model
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
P012: The effect of Oncostatin M on human intestinal organoids
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P013 The JAK-3 and TYK-2 / STAT pathways are activated in moderate to severe ulcerative colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P0130: Assessment of macrophage types in the intestinal tissue of treatment naïve Inflammatory Bowel Disease patients in relation to their disease and activation of the CCL2/CCR2 pathway
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM